Literature DB >> 21863402

Cystic fibrosis carrier screening in Veneto (Italy): an ethical analysis.

Tommaso Bruni1, Matteo Mameli, Gabriella Pravettoni, Giovanni Boniolo.   

Abstract

A recent study by Castellani et al. (JAMA 302(23):2573-2579, 2009) describes the population-level effects of the choices of individuals who underwent molecular carrier screening for cystic fibrosis (CF) in Veneto, in the northeastern part of Italy, between 1993 and 2007. We discuss some of the ethical issues raised by the policies and individual choices that are the subject of this study. In particular, (1) we discuss the ethical issues raised by the acquisition of genetic information through antenatal carrier testing; (2) we consider whether by choosing to procreate naturally these couples can harm the resulting child and/or other members of society, and what the moral implications of such harm would be; (3) we consider whether by choosing to avoid natural procreation carrier couples can harm current or future individuals affected by cystic fibrosis; (4) we discuss whether programs that make carrier testing available can be considered eugenic programs.

Entities:  

Mesh:

Year:  2012        PMID: 21863402     DOI: 10.1007/s11019-011-9347-7

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  5 in total

Review 1.  An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis.

Authors:  R Buzzetti; D Salvatore; E Baldo; M P Forneris; V Lucidi; D Manunza; I Marinelli; B Messore; A S Neri; V Raia; M L Furnari; G Mastella
Journal:  J Cyst Fibros       Date:  2009-05-06       Impact factor: 5.482

2.  Association between carrier screening and incidence of cystic fibrosis.

Authors:  Carlo Castellani; Luigi Picci; Anna Tamanini; Paolo Girardi; Paolo Rizzotti; Baroukh Maurice Assael
Journal:  JAMA       Date:  2009-12-16       Impact factor: 56.272

Review 3.  Cystic fibrosis.

Authors:  Brian P O'Sullivan; Steven D Freedman
Journal:  Lancet       Date:  2009-05-04       Impact factor: 79.321

Review 4.  The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions.

Authors:  Anne Vankeerberghen; Harry Cuppens; Jean-Jacques Cassiman
Journal:  J Cyst Fibros       Date:  2002-03       Impact factor: 5.482

Review 5.  Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders.

Authors:  Samuel M Moskowitz; James F Chmiel; Darci L Sternen; Edith Cheng; Ronald L Gibson; Susan G Marshall; Garry R Cutting
Journal:  Genet Med       Date:  2008-12       Impact factor: 8.822

  5 in total
  2 in total

1.  Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature.

Authors:  S Janssens; A De Paepe; P Borry
Journal:  J Community Genet       Date:  2012-12-29

2.  Genetic Testing for Minors: Comparison between Italian and British Guidelines.

Authors:  Pamela Tozzo; Luciana Caenazzo; Daniele Rodriguez
Journal:  Genet Res Int       Date:  2012-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.